Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Sales (2016 - 2025)

Historic Return on Sales for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to 0.08%.

  • Ptc Therapeutics' Return on Sales rose 6200.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 10300.0%. This contributed to the annual value of 0.78% for FY2024, which is 100.0% down from last year.
  • As of Q3 2025, Ptc Therapeutics' Return on Sales stood at 0.08%, which was up 6200.0% from 0.36% recorded in Q2 2025.
  • Over the past 5 years, Ptc Therapeutics' Return on Sales peaked at 0.74% during Q1 2025, and registered a low of 1.54% during Q4 2024.
  • Its 5-year average for Return on Sales is 0.69%, with a median of 0.8% in 2023.
  • In the last 5 years, Ptc Therapeutics' Return on Sales soared by 14000bps in 2021 and then crashed by -7400bps in 2024.
  • Over the past 5 years, Ptc Therapeutics' Return on Sales (Quarter) stood at 0.87% in 2021, then fell by -20bps to 1.04% in 2022, then rose by 24bps to 0.8% in 2023, then plummeted by -93bps to 1.54% in 2024, then skyrocketed by 105bps to 0.08% in 2025.
  • Its Return on Sales was 0.08% in Q3 2025, compared to 0.36% in Q2 2025 and 0.74% in Q1 2025.